CRISPR targeting of FOXL2 c.402C>G mutation reduces malignant phenotype in granulosa tumor cells and identifies anti-tumoral compounds.
Amarilla-Quintana S, Navarro P, Hernández I, Ramos A, Montero-Calle A, Cabezas-Sainz P, Barrero MJ, Megías D, Vilaplana-Martí B, Epifano C, Gómez-Dominguez D, Monzón S, Cuesta I, Sánchez L, Barderas R, García-Donas J, Martín A, Pérez de Castro I.
Amarilla-Quintana S, et al. Among authors: ramos a.
Mol Oncol. 2025 Jan 8. doi: 10.1002/1878-0261.13799. Online ahead of print.
Mol Oncol. 2025.
PMID: 39776254
Free article.